Advertisement

Prevention and Management of Apheresis Complications

  • Marleen M. Neyrinck
  • Hans VrielinkEmail author
Chapter
Part of the Advances and Controversies in Hematopoietic Transplantation and Cell Therapy book series (ACHTCT)

Abstract

Apheresis techniques are generally safe, and serious adverse events rarely occur. However, apheresis procedures cause major physiologic changes in donors and patients, including hypocalcemia due to citrate infusion, hemodynamic changes associated with fluid shifts, and/or depletion of cellular and plasma components. Moreover, adverse events may be unrelated to the apheresis procedure itself (e.g., hematomas and/or infections from line). In general, these adverse events can be system or local; they can also be differentiated based on the etiology, such as immunologic (e.g., side effects from admission of blood components and of ethylene oxide) and non-immunologic events (e.g., hypovolemia, hypocalcemia). Besides this, the complications can be acute (i.e., during the apheresis procedure) but can also happen hours, days, or maybe even years after apheresis procedure. Measures can be taken to avoid complications during apheresis to identify population at risks for these complications, for example, special considerations for children for whom therapeutic apheresis procedures are indicated to avoid complications.

References

  1. Buchta C, Macher M, Bieglmayer C, Höcker P, Dettke M (2003) Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate. Transfusion 43(11):1615–1621CrossRefGoogle Scholar
  2. Bueno JL, Castro E, García F, Barea L, González R (2006) Hematomas in multicomponent apheresis: searching for related factors. Transfusion 46:2184–2191CrossRefGoogle Scholar
  3. Horowitz SH (2000) Venipuncture-induced causalgia: anatomic relations of upper extremity superficial veins and nerves, and clinical considerations. Transfusion 40:1036–1040CrossRefGoogle Scholar
  4. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P (2004) Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44:1774–1789CrossRefGoogle Scholar
  5. Lee G, Arepally GM (2012) Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher 27:117–125CrossRefGoogle Scholar
  6. Newman BH, Waxman DA (1996) Blood donation-related neurologic needle injury: evaluation of 2 years’ worth of data from a large blood center. Transfusion 36:213–215CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of HematologyAZ DeltaRoeselareBelgium
  2. 2.Unit of Transfusion MedicineSanquin Blood SupplyAmsterdamThe Netherlands

Personalised recommendations